CervoMed Inc.
Biotechnology
Healthcare
CRVO
8.95 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.20
52 week high
17.51
high
8.43
52 week low
0.00
low
8.11
growth
-51.07 %
previous Close
8.16
P/E ratio
market cap
85.13 M
div yield
0
usd
Jun 2025
qoq
revenue
1.76 M
-8.31 %
net incoming
-6.26 M
-27.88 %
eps
0.00 %
-25.00 %
eps surprise
-2.94 %
net profit margin
-356.05 %
-100.00 %
operating incoming
-6.62 M
-24.76 %
net change in cash
-2.18 M
-245.19 %
cash on hand
8.32 M
-20.77 %
cost of revenue
0.00 %
top top